Phase II of oral satraplatin in patients with metastatic breast cancer (MBC).
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2012
At a glance
- Drugs Satraplatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Mar 2012 Actual patient (40) as reported by ClinicalTrials.gov.
- 14 Feb 2008 The expected completion date for this trial is now 1 Feb 2008.